Renaissance Technologies - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 44 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2017. The put-call ratio across all filers is 7.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$12
-50.0%
60,800
-12.4%
0.00%
Q1 2023$24
-11.1%
69,381
-16.2%
0.00%
Q4 2022$27
-99.7%
82,800
+319.4%
0.00%
Q2 2022$9,000
-94.6%
19,742
-70.8%
0.00%
Q4 2020$168,000
+90.9%
67,564
+88.2%
0.00%
Q3 2020$88,000
-58.3%
35,900
-39.5%
0.00%
Q2 2020$211,000
-13.9%
59,375
-43.3%
0.00%
Q1 2020$245,000
+214.1%
104,700
+193.4%
0.00%
Q4 2019$78,000
+122.9%
35,681
+84.0%
0.00%
Q3 2019$35,000
+59.1%
19,390
+30.1%
0.00%
Q2 2019$22,000
-90.8%
14,900
-72.7%
0.00%
Q2 2017$240,00054,5000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2017
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$44,0000.03%
Brown Advisory Securities, LLC 28,000$35,0000.02%
Murchinson Ltd. 76,404$96,0000.02%
WEBSTER BANK, N. A. 80,000$101,0000.01%
Patriot Financial Group Insurance Agency, LLC 34,650$44,0000.01%
WMS Partners, LLC 42,000$53,0000.01%
Willow Creek Wealth Management Inc. 18,724$24,0000.01%
Cubic Asset Management, LLC 14,000$18,0000.00%
CVI Holdings, LLC 45,993$58,0000.00%
One Day In July LLC 10,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders